• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[袢利尿剂对因心力衰竭住院患者血钠的影响]

[Impact of loop diuretics on blood sodium in patients hospitalized for heart failure].

作者信息

Guan Yu, Wu Xuesi, Xu Min, Wu Jiahui

机构信息

Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing 100029, China. Email:

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Jul;42(7):582-7.

PMID:25327601
Abstract

OBJECTIVE

To observe the level of blood sodium in patients hospitalized for heart failure with water-sodium retention treated with loop diuretics and risk factors of low blood sodium.

METHODS

We selected 1 378 acute decompensated heart failure patients who visited Anzhen Hospital, and they are treated with loop diuretics, 259 patients with weight loses more than 1 kg in one week was enrolled in the final analysis, and divided into 3 groups: Group A (weight reduction between 1-3 kg), Group B (weight reduction between 3-5 kg) and Group C (weight reduction over 5 kg). Blood sodium, creatinine and uric acid were compared among groups and risk factors of low blood sodium were analyzed.

RESULTS

Blood sodium was similar before and post loop diuretics treatment in Group A, and reduced in group B ((138.28 ± 3.73) mmol/L vs. (139.34 ± 3.66) mmol/L, P < 0.05) and in Group C((137.60 ± 4.07) mmol/L vs. (139.44 ± 4.12) mmol/L, P < 0.05). Forty-six (17.8%) patients developed hyponatremia post loop diuretics treatment. Duration of loop diuretics use was the independent risk infector for hyponatremia (OR = 1.191, 95%CI 1.010-1.385).

CONCLUSIONS

Loop diuretics use is safe for treating hospitalized patients for heart failure with water-sodium retention and the risk of developing hyponatremia is low. Duration of loop diuretics use is the independent risk factor of hyponatremia.

摘要

目的

观察襻利尿剂治疗水钠潴留性心力衰竭住院患者的血钠水平及低血钠的危险因素。

方法

选取1378例就诊于安贞医院的急性失代偿性心力衰竭患者,均接受襻利尿剂治疗,最终纳入1周内体重下降超过1kg的259例患者进行分析,并分为3组:A组(体重下降1-3kg)、B组(体重下降3-5kg)和C组(体重下降超过5kg)。比较各组血钠、肌酐和尿酸水平,并分析低血钠的危险因素。

结果

A组襻利尿剂治疗前后血钠水平相似,B组((138.28±3.73)mmol/L对(139.34±3.66)mmol/L,P<0.05)和C组((137.60±4.07)mmol/L对(139.44±4.12)mmol/L,P<0.05)血钠降低。46例(17.8%)患者襻利尿剂治疗后发生低钠血症。襻利尿剂使用时间是低钠血症的独立危险因素(OR=1.191,95%CI 1.010-1.385)。

结论

襻利尿剂用于治疗水钠潴留性心力衰竭住院患者是安全的,发生低钠血症的风险较低。襻利尿剂使用时间是低钠血症的独立危险因素。

相似文献

1
[Impact of loop diuretics on blood sodium in patients hospitalized for heart failure].[袢利尿剂对因心力衰竭住院患者血钠的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Jul;42(7):582-7.
2
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中,静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标,尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
3
Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion.袢利尿剂可导致临床性利钠衰竭:一种容量扩张的处方。
Congest Heart Fail. 2009 Jan-Feb;15(1):1-4. doi: 10.1111/j.1751-7133.2008.00037.x.
4
Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.心力衰竭中的低氯血症与利尿剂抵抗:机制洞察
Circ Heart Fail. 2016 Aug;9(8). doi: 10.1161/CIRCHEARTFAILURE.116.003180.
5
Association of hyponatremia to diuretic response and incidence of increased serum creatinine levels in hospitalized patients with acute decompensated heart failure.急性失代偿性心力衰竭住院患者低钠血症与利尿剂反应及血清肌酐水平升高发生率的相关性
Cardiology. 2014;128(4):333-42. doi: 10.1159/000360604. Epub 2014 Jun 17.
6
Hyponatremia in acute decompensated heart failure: depletion versus dilution.急性失代偿性心力衰竭中的低钠血症:耗竭与稀释。
J Am Coll Cardiol. 2015 Feb 10;65(5):480-92. doi: 10.1016/j.jacc.2014.12.010.
7
Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.急性失代偿性心力衰竭患者的袢利尿剂策略:一项随机对照试验的荟萃分析。
J Crit Care. 2014 Feb;29(1):2-9. doi: 10.1016/j.jcrc.2013.10.009. Epub 2013 Oct 29.
8
Loop diuretics for heart failure-associated hyponatremia.用于治疗心力衰竭相关性低钠血症的袢利尿剂
Am J Med. 2010 Aug;123(8):e5-6. doi: 10.1016/j.amjmed.2009.12.035.
9
Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.在充血性心力衰竭和肾功能不全患者中,联用托伐普坦并减少襻利尿剂可改善充血症状并改善肾功能不全。
Heart Vessels. 2017 Mar;32(3):287-294. doi: 10.1007/s00380-016-0872-4. Epub 2016 Jul 6.
10
In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.在右心或双心室慢性心力衰竭中,将噻嗪类药物添加到袢利尿剂中以实现对肾单位的序贯阻断,与稀释性低钠血症风险增加相关:一项病例对照研究的结果。
Minerva Cardioangiol. 2012 Oct;60(5):517-29.